Rabih Said

575 total citations
33 papers, 390 citations indexed

About

Rabih Said is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Rabih Said has authored 33 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 12 papers in Molecular Biology and 8 papers in Cancer Research. Recurrent topics in Rabih Said's work include Cancer Genomics and Diagnostics (8 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Cancer Treatment and Pharmacology (4 papers). Rabih Said is often cited by papers focused on Cancer Genomics and Diagnostics (8 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Cancer Treatment and Pharmacology (4 papers). Rabih Said collaborates with scholars based in United States, Lebanon and Canada. Rabih Said's co-authors include Apostolia M. Tsimberidou, David S. Hong, Aung Naing, Gerald S. Falchook, Siqing Fu, Razelle Kurzrock, Sarina A. Piha‐Paul, Jennifer J. Wheler, Geoffrey R. Oxnard and Qun Dai and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Rabih Said

31 papers receiving 386 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rabih Said United States 11 153 118 118 105 70 33 390
Ratislav Bahleda France 12 218 1.4× 114 1.0× 168 1.4× 128 1.2× 39 0.6× 31 458
Claudia Arce-Salinas Mexico 11 241 1.6× 177 1.5× 138 1.2× 80 0.8× 47 0.7× 25 448
Yingwei Qi United States 13 333 2.2× 106 0.9× 223 1.9× 165 1.6× 40 0.6× 23 681
Leung Li Hong Kong 14 209 1.4× 98 0.8× 132 1.1× 104 1.0× 82 1.2× 33 571
Sophie Barrett United Kingdom 9 295 1.9× 161 1.4× 256 2.2× 54 0.5× 59 0.8× 18 660
Anna Maria Elisabeth Walenkamp Netherlands 9 271 1.8× 73 0.6× 117 1.0× 68 0.6× 79 1.1× 17 467
Jason B. Litten United States 9 132 0.9× 87 0.7× 202 1.7× 87 0.8× 39 0.6× 21 537
Ida Paris Italy 16 370 2.4× 167 1.4× 210 1.8× 189 1.8× 70 1.0× 72 870
M. Holtkamp Netherlands 9 220 1.4× 81 0.7× 128 1.1× 37 0.4× 98 1.4× 13 442
Sara Nunnery United States 8 115 0.8× 53 0.4× 158 1.3× 83 0.8× 44 0.6× 15 352

Countries citing papers authored by Rabih Said

Since Specialization
Citations

This map shows the geographic impact of Rabih Said's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rabih Said with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rabih Said more than expected).

Fields of papers citing papers by Rabih Said

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rabih Said. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rabih Said. The network helps show where Rabih Said may publish in the future.

Co-authorship network of co-authors of Rabih Said

This figure shows the co-authorship network connecting the top 25 collaborators of Rabih Said. A scholar is included among the top collaborators of Rabih Said based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rabih Said. Rabih Said is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dexheimer, Thomas S., Nathan P. Coussens, Thomas Silvers, et al.. (2025). Combinatorial screen of targeted agents with the PI3K inhibitors inavolisib, alpelisib, duvelisib, and copanlisib in multi-cell type tumor spheroids. SLAS DISCOVERY. 32. 100222–100222. 2 indexed citations
2.
Mattes, Malcolm D., Henning Willers, Yong Lin, et al.. (2024). CTEP 10492, a phase 1/1b study of the AKT inhibitor ipatasertib with chemoradiation for locally advanced head and neck squamous cell carcinoma.. Journal of Clinical Oncology. 42(16_suppl). TPS6127–TPS6127. 2 indexed citations
3.
Yap, Timothy A., Sarina A. Piha‐Paul, Daniel D. Karp, et al.. (2023). 701P NCI10221: Phase II multicenter biomarker driven combination trial of copanlisib and nivolumab in patients with molecularly-selected advanced solid tumors (BaCoN). Annals of Oncology. 34. S487–S488. 1 indexed citations
4.
Bagegni, Nusayba A., Leslie Nehring, J. L. Anderson, et al.. (2022). A phase I/II trial evaluating the safety and efficacy of eribulin in combination with copanlisib in patients with metastatic triple-negative breast cancer (TNBC).. Journal of Clinical Oncology. 40(16_suppl). TPS1128–TPS1128. 3 indexed citations
5.
Raad, Roy A., et al.. (2021). Aplastic anemia secondary to dual cancer immunotherapies a physician nightmare: case report and literature review. Allergy Asthma and Clinical Immunology. 17(1). 112–112. 6 indexed citations
6.
Tarek, Nidale, Rabih Said, Clark R. Andersen, et al.. (2020). Primary Ewing Sarcoma/Primitive Neuroectodermal Tumor of the Kidney: The MD Anderson Cancer Center Experience. Cancers. 12(10). 2927–2927. 12 indexed citations
7.
Said, Rabih, et al.. (2019). Chronic Myeloid Leukemia in a Patient Receiving Tofacitinib: A Case Report and Literature Review. SHILAP Revista de lepidopterología. 2019. 1–4.
8.
Said, Rabih & Apostolia M. Tsimberidou. (2019). Basket Trials and the MD Anderson Precision Medicine Clinical Trials Platform. The Cancer Journal. 25(4). 282–286. 9 indexed citations
9.
Fountzilas, Elena, Rabih Said, & Apostolia M. Tsimberidou. (2018). Expanded access to investigational drugs: balancing patient safety with potential therapeutic benefits. Expert Opinion on Investigational Drugs. 27(2). 155–162. 26 indexed citations
10.
Said, Rabih, Yang Ye, David S. Hong, et al.. (2016). Phase I clinical trial of lenalidomide in combination with 5-fluorouracil, leucovorin, and oxaliplatin in patients with advanced cancer. Cancer Chemotherapy and Pharmacology. 77(3). 575–581. 8 indexed citations
11.
Tsimberidou, Apostolia M., Rabih Said, Kirk S. Culotta, et al.. (2015). Phase I study of azacitidine and oxaliplatin in patients with advanced cancers that have relapsed or are refractory to any platinum therapy. Clinical Epigenetics. 7(1). 29–29. 14 indexed citations
12.
Said, Rabih, Razelle Kurzrock, Aung Naing, et al.. (2015). Dose-finding study of hepatic arterial infusion of irinotecan-based treatment in patients with advanced cancers metastatic to the liver. Investigational New Drugs. 33(4). 911–920. 4 indexed citations
13.
Bilen, Mehmet Asım, Jean‐Bernard Durand, Kenneth R. Hess, et al.. (2014). Evaluation of a novel blood pressure scoring method and its association with clinical response in cancer patients treated with anti-vascular endothelial growth factor therapy. Investigational New Drugs. 32(4). 717–722. 3 indexed citations
14.
Said, Rabih, José Banchs, Kenneth R. Hess, et al.. (2013). The prognostic significance of left ventricular ejection fraction in patients with advanced cancer treated in phase I clinical trials. Annals of Oncology. 25(1). 276–282. 6 indexed citations
15.
Hong, David S., Rabih Said, Gerald S. Falchook, et al.. (2013). Phase I Study of BIIB028, a Selective Heat Shock Protein 90 Inhibitor, in Patients with Refractory Metastatic or Locally Advanced Solid Tumors. Clinical Cancer Research. 19(17). 4824–4831. 20 indexed citations
16.
17.
Said, Rabih, David S. Hong, Jennifer J. Wheler, et al.. (2012). p53 mutations in advanced cancers: Clinical characteristics and outcomes in a phase I setting.. Journal of Clinical Oncology. 30(15_suppl). 10607–10607. 3 indexed citations
18.
Said, Rabih, et al.. (2011). Intracranial Rosai-Dorfman. The Neurologist. 17(2). 117–119. 11 indexed citations
19.
Said, Rabih, Eileen M. O’Reilly, Leslie H. Blumgart, Jinru Shia, & Ghassan K. Abou‐Alfa. (2010). Pancreatic islet cell carcinoma presenting with concurrent Cushing's and Zollinger–Ellison syndromes: case series and literature review. European Journal of Gastroenterology & Hepatology. 22(2). 246–252. 3 indexed citations
20.
Desai, Nisarg, et al.. (2010). Choriocarcinoma in a 73-year-old woman: a case report and review of the literature. Journal of Medical Case Reports. 4(1). 379–379. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ratislav Bahleda Breakdown of academic impact, for papers by Claudia Arce-Salinas Breakdown of academic impact, for papers by Yingwei Qi Breakdown of academic impact, for papers by Leung Li Breakdown of academic impact, for papers by Sophie Barrett Breakdown of academic impact, for papers by Anna Maria Elisabeth Walenkamp Breakdown of academic impact, for papers by Jason B. Litten Breakdown of academic impact, for papers by Ida Paris Breakdown of academic impact, for papers by M. Holtkamp Breakdown of academic impact, for papers by Sara Nunnery
Rankless by CCL
2026